 This is a randomized, Phase II study designed to investigate Nimotuzumab plus whole-brain radiation therapy WBRTand to compare it rith WBRT alone in patients with brain metastases from non-small cell lung cancer NSCLC. The purpose of the study is to assess the efficacy of nimotuzumab in combination with WBRT. 